Xenter today announced that it has appointed Mark Turco as president of its Xenter Medical Technologies business unit.
Turco most recently served as executive vice president of research & development and global chief medical officer at Sirtex Medical. He has also served as chief medical officer of Covidien and later as vice president and chief medical officer of Medtronic’s aortic, peripheral and vascular divisions. Turco has also held leadership roles at the University of Pennsylvania’s Penn Center for Innovation and had a clinical practice at Washington Adventist Hospital.
“I am very excited to join Xenter in this pivotal leadership role,” Turco said in a news release. “I look forward to aiding in the development of medical technologies using Xenter’s three pillars: medical devices, health data, and therapeutic drugs. I am joining a globally recognized and experienced team that has been tasked with transforming the collection of procedural and patient data using a new global platform that leverages smart wireless medical technologies. This platform seeks to provide new techniques for both therapeutic drug discovery and the improvement of medical procedures, all of which translates to better outcomes for patients. My combined experiences to date have provided me with the unique skills to lead this multi-disciplinary team of technologists, scientists, and engineers.”
Xenter’s Medical Technologies unit is developing a global platform of smart medical devices that focus on vascular imaging and physiology technologies for interventional medical procedures.
“Xenter is continuing our commitment to bringing the most experienced and visionary leaders to the world’s first purpose-built medical device-data-drug company and tasking them with introducing change, developing new wireless platforms for smart medical devices, and harnessing the power of Physical Intelligence to improve patient care. As a former patient, my goal has been to work with people like Mark Turco, MD, to develop the medical technologies platform of the future and characterize the differences between AI and PI,” founder and CEO Richard Linder said. “Dr. Turco brings a wealth of skill and insight to Xenter and possesses the clinical knowledge and industry experience to drive the change we desire to achieve in medical devices and data.”